Clinical Trial Update: Remote Preconditioning and Myocardial Protection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial conducted by Assiut University evaluating remote preconditioning for myocardial protection in congenital heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Snippet

Sponsor: Assiut University | Conditions: Congenital Heart Disease | Phase 2 | Status: COMPLETED